Dainippon Sumitomo up 277yen also.
They only have the Japanese and Asian market.
Paid ICPT $15m in 2011 with milestone
payments of $300m.
NASH effects about 5% of the lean population,
20% of the obese and 50% of morbidly obese.
The US market is the gold market.
Maybe someone will step up.
It's been 2 years since the FDA approved IMC's
2b trial for NASH.
immuron 2b nash trial
There's ASH NASH c.difficile research and revenue from
Travelan.
technical analysis, page-131
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $22.79M | |||
| Open | High | Low | Value | Volume |
| 9.5¢ | 10.0¢ | 9.5¢ | $63.51K | 640.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 127000 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 171190 | 4 |
View Market Depth
| Last trade - 15.48pm 16/07/2024 (20 minute delay) ? |
| IMC (ASX) Chart |